Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 831-838

  Wang, Jiyang ^a   Koizumi, Toshiki ^a   Watanabe, Takeshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULONEPHRITIS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLENOMEGALY;

EID: 0029838991     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.831     Document Type: Article

References (57)

1. Bolen, J.B. 1995. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr. Opin. Immunol. 7:306-311.
2. Yamanashi, Y., T. Kakiuchi, J. Mizuguchi, T. Yamamoto, and K. Toyoshima. 1991. Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science (Wash. DC). 251:192-194.
3. Burkhardt, A.L., M. Brunswick, J.B. Bolen, and J.J. Mond. 1991. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA. 88:7410-7414.
4. Campbell, M.-A., and B.M. Sefton. 1992. Association between B-lymphocyte membrane immunoglobulin and multiple members of the src family of protein tyrosine kinases. Mol. Cell. Biol. 12:2315-2321.
5. Li, Z-.H., S. Mahajan, M.M. Prendergast, J. Fargnoli, X. Zhu, S. Klages, D. Adam, G.L. Schieven, J. Blake, J.B. Bolen, and A.L. Burkhardt. 1992. Cross-linking of surface immunoglobulin activates src-related tyrosine kinases in WEH1231 cells. Biochem. Biophys. Res. Commun. 187:1536-1544.
6. Hutchcroft, J.E., M.L. Harrison, and R.L. Geahlen. 1992. Association of the 72-kD protein-tyrosine kinase PTK72 with the B cell antigen receptor. J. Biol. Chem. 267:8613-8619.
7. Yamada, T., T. Tamguchi, C. Yang, S. Yasue, H. Saito, and H. Yamamura. 1993. Association with B-cell-antigen receptor with protein-tyrosine kinase p72syk and activation by engagement of membrane IgM. Eur. J. Biochem. 213:455-459.
8. Gold, M.R., D.A. Law, and A.L. DeFranco. 1990. Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor. Nature (Lond.). 345:810-813.
9. Campbell, M.-A., and B.M. Sefton. 1990. Protein tyrosine phosphorylation is induced in murine B lymphocytes in response to stimulation with anti-immunoglobulin. EMBO (Eur. Mol. Biol. Organ.) J. 9:2125-2131.
10. Gold, M.R., L. Matsuuchi, R.B. Kelly, and A.L. DeFranco. 1991. Tyrosine phosphorylation of components of the B-cell antigen receptor following receptor crosslinking. Proc. Natl. Acad. Sci. USA. 88:3436-3440.
11. Coggeshall, K.M. J.C. McHugh, and A. Altman. 1992. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase C-γ2 in B lymphocytes. Proc. Natl. Acad. Sci. USA 89:5660-5664.
12. Yamanashi, Y., Y. Fukui, B. Wongsasant, Y. Kinoshita, Y. Ichimori, K. Toyoshima, and T. Yamamoto. 1992. Activation of src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 89: 1118-1122.
13. Gold, M.R., V.W.-F. Chan, C.W. Turck, and A.L. DeFranco. 1992. Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes. J. Immunol. 148: 2012-2022.
14. Bustelo, X.R., and M. Barbacid. 1992. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science (Wash. DC). 256:1196-1199.
15. Bustelo, X.R., J.A. Ledbetter, and M. Barbacid. 1992. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature (Lond.). 356:68-71.
16. Margolis, B., P. Hu, S. Katzav, W. Li, J.M. Oliver, A. Ullrich, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature (Lond.). 356:71-74.
17. ras GTPase-activating protein (GAP) and two GAP-associated proteins. J. Immunol. 150:377.
18. 21 ras oncoprotein activator SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein. J. Immunol. 153:623-636.
19. Yamanashi, Y., M. Okada, T. Semba, T. Yamor, H. Uemori, S. Tsunasawa, K. Toyoshima, D. Kitamura, T. Watanabe, and T. Yamamoto. 1993. Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA. 90:3631-3635.
20. lyn, in hematopoietic cells and association with production of human T cell lymphotropic virus type I. Proc. Natl. Acad. Sci. USA. 86:6538-6542.
21. Umemori, H., A. Wanaka, H. Kata, M. Takeuchi, M. Tohyama, and T. Yamamoto. 1992. Specific expression of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Mol. Brain Res. 16:303-310.
22. lyn and a 120-kDa phosphoprotein. Proc. Natl. Acad. Sci. USA. 92:359-363.
23. Aoki, Y., Y-T. Kim, R. Stillwell, T.J. Kim, and S. Pillai. 1995. The SH2 domains of src family kinases associate with Syk. J. Biol. Chem. 270:15658-15663.
24. lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 183:675-680.
25. Justement, L.B., K.S. Campbell, N.C. Chien, and J.C. Cambier. 1991. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science (Wash. DC). 252:1839-1842.
26. Kishihara, K., J. Penninger, V.A. Wallace, T.M. Kundig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P.S. Ohashi, M.L. Thomas et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell. 74:143-156.
27. Pesando, J.M., L.S. Bouchard, and B.E. McMaster. 1989. CD19 is functionally and physically associated with surface immunoglobulin. J. Exp. Med. 170:2159-2164.
28. Pezzutto, A., B. Dorken, P.S. Rabinovitch, J.A. Ledbetter, G. Moldenhauer, and E.A. Clark. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138:2793-2799.
29. Brown, V.K., E.W. Ogle, A.L. Burkhardt, R.B. Rowley, J.B. Bolen, and L.B. Justement. 1994. J. Biol. Chem. 269: 17238-17244.
30. van Noesel, C.J.M., A.C. Lankester, G.M.W. van Schijndel, and R.A.W. van Lier. 1993. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. Int. Immunol. 5:699-705.
31. 2+ mobilization through distinct pathways. EMBO (Eur. Mol. Biol. Organ.) J. 13:1341-1349.
32. Scheuermann, R.H., E. Racila, T. Tucker, E. Yefenof, N.E. Street, E.S. Vitetta, L.J. Picker, and J.W. Uhr. 1994. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc. Natl. Acad. Sci. USA. 91: 4048-4052.
33. Ren, C.L., T. Morio, S.M. Fu, and R.S. Geha. 1994. Signal transduction via CD40 involves activation of Lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation at phospholipase Cγ2. J. Exp. Med. 179:673-680.
34. Faris, M., F. Gaskin, J.T. Parsons, and S.M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923-1931.
35. Liu, Y.-J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C.M. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centers. Nature (Lond.). 342: 929-931.
36. Banchereau, J., P.D. Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on Interleukin-4 and antibody to CD40. Science (Wash. DC). 251:70-72.
37. Kehry, M.R. 1996. CD40-mediated signaling in B cells: balancing cell survival, growth, and death. J. Immunol. 156: 2345-2348.
38. Hibbs, M.L., D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker, and A.R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:301-311.
39. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 3:549-560.
40. Garrone, P., E.-M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265-1273.
41. Schattner, E.J., K.B. Elkon, D.-H. Yoo, J. Tumang, P.H. Krammer, M.K. Crow, and S.M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557-1565.
42. Wang, J., I. Taniuchi, Y. Maekawa, M. Howard, M.D. Cooper, and T. Watanabe. 1996. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26:92-96.
43. Rothstein, T.L., J.K.M. Wang, D.J. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S.-T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (Lond.). 374:163-165.
44. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
45. Phillips, N.E., and D.C. Parker. 1983. Fc-dependent inhibition of mouse B cell activation by whole anti-μ antibodies. J. Immunol. 130:602-606.
46. Fridman, W.H., C. Bonnerot, M. Daeron, S. Amigorena, J.-L. Teillaud, and C. Sautes. 1992. Structural bases of Fcγ receptor functions. Immunol. Rev. 125:49-76.
47. D'Ambrosio, D., K.L. Hippen, S.A. Minskoff, I. Mellman, C. Pani, K.A. Siminovitch, and J.C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science (Wash. DC). 268:293-297.
48. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-defident mice. Nature (Lond.). 379:346-349.
49. Pani, G., M. Kozlowski, J.C. Cambier, G.B. Mills, and K.A. Siminovitch. 1995. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181: 2077-2084.
50. Cyster, J.G., and C.C. Goodnow. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines threshold for negative selection. Immunity. 2:13-24.
51. Kozlowski, M., I. Mlinaric-Rascan, G.S. Feng, R. Shen, A. Pawson, and K.A. Siminovitch. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178:2157-2163.
52. Tsui, H.W., K.A. Siminovitch, L. de Souza, and F.W.L. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the hemopoietic cell phosphatase gene. Nature Genet. 4:124-129.
53. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Mutations at the motheaten locus are within the hemopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1445-1454.
54. Davidson, W.F., H.C. Morse III, S.O. Sharrow, and T.M. Chused. 1979. Phenotypic and functional effects of the motheaten gene on inurine B and T lymphocytes. J. Immunol. 122:884-891.
55. Okumura, M., and M.L. Thomas. 1995. Regulation of immune function by protein tyrosine phosphatases. Curr. Opin. Immunol. 7:312-319.
56. + B cells in viable motheaten and normal mice. Science (Wash. DC). 232:1423-1425.
57. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.